Espen Molden

Norway

Research Interests

Explore related searches

Professors in Norway

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (16)

Se Hyun Kim

Seoul National University

SOUTH KOREA

View details

Erik Eliasson

Karolinska Institutet

SWEDEN

View details

Anto P. Rajkumar

Clinical Associate Professor in old age Psychiatry

University of Nottingham

UNITED KINGDOM

View details

Magnus Ingelman-Sundberg

Karolinska Institutet

SWEDEN

View details

Kristine Hole

Adjunct Associate Professor

OsloMet – Oslo Metropolitan University

NORWAY

View details

Chin B. Eap

SWITZERLAND

View details

Sara Margolin

Karolinska Institutet

SWEDEN

View details

Emilio Fernandez-Egea

University of Cambridge

UNITED KINGDOM

View details

Anssi Solismaa

University of Tampere

FINLAND

View details

Yi-lang Tang

Emory University School of Medicine

UNITED STATES

View details

Ian McGrane

UNITED STATES

View details

Siobhan Lock

Cardiff University

UNITED KINGDOM

View details

Henk-Jan Guchelaar

Leiden University Medical Center

NETHERLANDS

View details

Georgios Schoretsanitis

University of Zurich

SWITZERLAND

View details

Nadine Parker

University of Oslo

NORWAY

View details

Jesse Swen

Full professor of clinical pharmacy, in particular translational pharmacogenetics

Leiden University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Espen Molden

Research Interests

Explore related searches

Contact this professor

Articles (20)

Polygenic overlap with granulocyte counts identifies novel loci for clozapine metabolism and clozapine-induced agranulocytosis

CYP2D6 genotype and outcome in tamoxifen treated early breast cancer

Improved Prediction of CYP2D6 Catalyzed Drug Metabolism by Taking Variant Substrate Specificities and Novel Polymorphic Haplotypes into Account

Solanidine analysis during therapeutic drug monitoring revealed rare CYP2D6 poor metabolizer genotype: A case report

Impact of CYP2D6 genotype on fluoxetine exposure and treatment switch in adults and children/adolescents

Correlation Between Clozapine and CRP Levels in Relation to Smoking Status

Impact of the transcription factor nuclear factor 1 B T>C polymorphism on clozapine metabolism in vivo and expression of intestinal transporters in vitro

Therapeutic drug monitoring, liquid biopsies or pharmacogenomics for prediction of human drug metabolism and response

Combined effect of CYP2C19 and CYP2D6 genotypes on escitalopram serum concentration and its metabolic ratio in a European patient population

Apixaban removal during emergency surgery for type A acute aortic dissection: a prospective cohort study

Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition

Evidence for solanidine as a dietary CYP2D6 biomarker: Significant correlation with risperidone metabolism

Impact of NFIB and CYP1A variants on clozapine serum concentration—A retrospective naturalistic cohort study on 526 patients with known smoking habits

Implementation of pharmacogenetic testing in medication reviews in a hospital setting

Impact of age, sex and cytochrome P450 genotype on quetiapine and N‐desalkylquetiapine serum concentrations: A study based on real‐world data from 8118 patients

Effect of CYP2D6 and CYP2C19 genotypes on atomoxetine serum levels: A study based on therapeutic drug monitoring data

Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites—a study in 839 patients with known CYP2D6 genotype

Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients

An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels.

Collaborators (16)

Se Hyun Kim

Erik Eliasson

Anto P. Rajkumar

Magnus Ingelman-Sundberg

Kristine Hole

Chin B. Eap

Sara Margolin

Emilio Fernandez-Egea

Anssi Solismaa

Yi-lang Tang

Ian McGrane

Siobhan Lock

Henk-Jan Guchelaar

Georgios Schoretsanitis

Nadine Parker

Jesse Swen

Make your next move.